Postmenopausal hormone therapy and breast cancer: an uncertain trade-off

JAMA. 2010 Oct 20;304(15):1719-20. doi: 10.1001/jama.2010.1528.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Aged
  • Breast Neoplasms / mortality*
  • Breast Neoplasms / pathology
  • Decision Making
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Combinations
  • Estrogens, Conjugated (USP) / adverse effects*
  • Estrogens, Conjugated (USP) / therapeutic use
  • Female
  • Hormone Replacement Therapy / adverse effects*
  • Humans
  • Medroxyprogesterone Acetate / adverse effects*
  • Medroxyprogesterone Acetate / therapeutic use
  • Postmenopause*
  • Risk

Substances

  • Drug Combinations
  • Estrogens, Conjugated (USP)
  • Prempro
  • Medroxyprogesterone Acetate